ANGIOTENSIN CONVERTING ENZYME INHIBITORS FOR TREATING OPTIC NEUROPATHY OR CONGENITAL OPTIC ATROPHY Russian patent published in 2018 - IPC A61K31/401 A61K31/403 A61K9/08 A61P27/02 

FIELD: medicine.

SUBSTANCE: group of inventions relates to the field of medicine, specifically to ophthalmology, and is intended for treating Leber's hereditary optic neuropathy. As an ophthalmic neuroprotector in the treatment of Leber's hereditary optic neuropathy, an ophthalmic composition is used, said composition comprising at least one angiotensin-converting enzyme (ACE) inhibitor and a pharmaceutically acceptable carrier. Also, said composition is used as an ophthalmic neuroprotector to maintain or improve the visual function of a person suffering from Leber's hereditary optic neuropathy.

EFFECT: use of the group of inventions provides effective treatment of Leber's hereditary optic neuropathy and effective maintenance or improvement of the visual function of the person suffering from Leber's hereditary optic neuropathy.

29 cl, 7 dwg, 6 ex